Aclidinium: A guide to its use in chronic obstructive pulmonary disease in the EU

被引：0
|
作者：
Scott L.J. [1 ]
Lyseng-Williamson K.A. [1 ]
Frampton J.E. [1 ]
机构：
[1] Adis, 41 Centorian Drive, Private Bag 65901, Mairangi Bay, North Shore 0754, Auckland
来源：
Drugs & Therapy Perspectives | 2013年 / 29卷 / 2期
关键词：
Chronic Obstructive Pulmonary Disease; Chronic Obstructive Pulmonary Disease Patient; Formoterol; Tiotropium; Major Adverse Cardiovascular Event;
D O I：
10.1007/s40267-013-0014-3
中图分类号：
学科分类号：
摘要：
Inhaled aclidinium (Eklira® Genuair® [EU]; Bretaris® Genuair® [EU]; Tudorza™ Pressair™ [US]) is a long-acting antimuscarinic agent. In the EU, it is indicated as maintenance bronchodilator treatment in patients with chronic obstructive pulmonary disease (COPD). Aclidinium provides improvements in lung function, dyspnoea and disease-specific health status in patients with COPD, and is generally well tolerated. © 2013 Springer International Publishing Switzerland.
引用
收藏
页码：34 / 39
页数：5
相关论文
共 50 条
  • [31] Pharmacokinetics and safety of aclidinium bromide in younger and elderly patients with chronic obstructive pulmonary disease
    de la Motte, Stephan
    Beier, Jutta
    Schmid, Karin
    Pascual, Silvia
    Maria Jansat, Josep
    Garcia Gil, Esther
    INTERNATIONAL JOURNAL OF CLINICAL PHARMACOLOGY AND THERAPEUTICS, 2012, 50 (06) : 403 - 412
  • [32] Dual bronchodilator therapy with aclidinium bromide/formoterol fumarate for chronic obstructive pulmonary disease
    D'Urzo, Tony
    Donohue, James F.
    Price, David
    Miravitlles, Marc
    Kerwin, Edward
    EXPERT REVIEW OF RESPIRATORY MEDICINE, 2015, 9 (05) : 519 - 532
  • [33] ACLIDINIUM/FORMOTEROL FIXED-DOSE COMBINATION FOR THE TREATMENT OF CHRONIC OBSTRUCTIVE PULMONARY DISEASE
    Cazzola, M.
    Calzetta, L.
    Matera, M. G.
    DRUGS OF TODAY, 2015, 51 (02) : 97 - 105
  • [34] Budesonide/formoterol pressurized metered-dose inhaler: a guide to its use in chronic obstructive pulmonary disease
    Drugs & Therapy Perspectives, 2010, 26 (11) : 6 - 9
  • [35] Fluticasone furoate/vilanterol dry-powder inhaler: a guide to its use in chronic obstructive pulmonary disease
    McKeage K.
    Drugs & Therapy Perspectives, 2015, 31 (4) : 112 - 117
  • [36] Formoterol/budesonide pressurized metered-dose inhaler: A guide to its use in chronic obstructive pulmonary disease
    Lyseng-Williamson K.A.
    Drugs & Therapy Perspectives, 2014, 30 (8) : 269 - 275
  • [37] PULMONARY REHABILITATION IN CHRONIC OBSTRUCTIVE PULMONARY-DISEASE (COPD) WITH RECOMMENDATIONS FOR ITS USE
    DONNER, CF
    HOWARD, P
    AMBROSINO, N
    BARDSLEY, P
    CLARK, CJ
    CORNUDELLA, R
    FITTING, JW
    FOLGERING, H
    IOLI, F
    MUIR, JF
    PATESSIO, A
    RAMPULLA, C
    SERGYSELS, R
    SMEETS, F
    STROM, K
    WORTH, H
    ZIELINSKI, J
    EUROPEAN RESPIRATORY JOURNAL, 1992, 5 (02) : 266 - 275
  • [38] Aclidinium Bromide In Patients With Chronic Obstructive Pulmonary Disease: Efficacy And Safety Results From ATTAIN
    Jones, P. W.
    Agusti, A.
    Bateman, E. D.
    Singh, D.
    Lamarca, R.
    de Miquel, G.
    Caracta, C.
    Gil, E. Garcia
    AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2011, 183
  • [39] INDIRECT COMPARISON OF EXACERBATION FREQUENCY BETWEEN ACLIDINIUM AND TIOTROPIUM IN PATIENTS WITH CHRONIC OBSTRUCTIVE PULMONARY DISEASE
    Lee, H.
    Choi, S. E.
    Bae, E.
    Lim, E. A.
    Kim, J.
    Park, H.
    VALUE IN HEALTH, 2014, 17 (07) : A589 - A589
  • [40] The use of theophylline in chronic obstructive pulmonary disease
    Pauwels, R
    CLINICAL AND EXPERIMENTAL ALLERGY, 1996, 26 : 55 - 59
12345